Mechanism of human umbilical cord blood CD34+ cell-derived exosomes improving chronic lower limb ischemia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043058

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-02-18

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower limb ischemia

Interventions

case series:Nil

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged 20-40 years; Single pregnancy; Term delivery; Spontaneous vaginal delivery; Live-birth.

Exclusion criteria

Exclusion criteria: Infectious diseases such as hepatitis B, hepatitis C, syphilis and AIDS.

Design outcomes

Primary

Measure	Time frame
human umbilical cord blood mononuclear cell;	—

Countries

China

Contacts

Public ContactGuo Juanjuan

Shenzhen Second People's Hospital

459879644@qq.com+86 15116331775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026